234
Participants
Start Date
September 30, 2007
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2012
behavioral drug and HIV risk reduction counseling (BDRC)
BDRC utilizes short-term behavioral contracts to promote abstinence and reduce drug- and sex-related HIV risk behaviors and can be provided by nurses and medical assistants available in medical settings in Malaysia.
abstinence-contingent buprenorphine (ACB)
Participants achieving heroin abstinence documented by an opioid-negative urine test receive take-home doses of buprenorphine-naloxone, with the number of take-home doses permitted increasing depending on the number of consecutive opioid-negative urine tests. Participants who test positive receive all doses of buprenorphine-naloxone under direct observation in the clinic, using a three-times per week dosing protocol.
Substance Abuse Research Center, Muar town
Yale University School of Medicine, New Haven
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER